TPG-backed Sai Life Sciences IPO: Right here’s what GMP indicators forward of situation opening on Wednesday, December 11

Must read

Abhishek Mukherjee
Abhishek Mukherjeehttps://www.hospitalitycareerprofile.com/
Abhishek Mukherjee is a seasoned market analyst with a deep understanding of financial trends and economic shifts. With years of experience in the field, Abhishek brings insightful analysis and up-to-date market news to help readers stay informed. His expertise spans stock markets, financial forecasts, and economic policy changes, making him a trusted voice in the industry.
- Advertisement -

TPG-backed Sai Life Sciences IPO is scheduled to open on Wednesday, December 11, and shut on Friday, December 13. The main points on allocation to anchor buyers for Sai Life Sciences IPO will likely be out Tuesday, December 10. Sai Life Sciences IPO value band has been mounted within the vary of 522 to 549 per fairness share of face worth of Re 1.

The agency is a contract analysis, improvement, and manufacturing organisation (CRDMO) that emphasizes innovation. Backed by the personal fairness large TPG Capital, the agency provides complete companies all through the whole drug discovery, improvement, and manufacturing course of for small-molecule new chemical entities (NCE) to pharmaceutical innovator corporations and biotechnology corporations worldwide.

- Advertisement -

As per the purple herring prospectus (RHP), the corporate’s listed friends are Divi’s Laboratories Ltd (with a P/E of 103.04), Suven Prescription drugs Ltd (with a P/E of 109.37), and Syngene Worldwide Ltd (with a P/E of 73.59).

For the six-month interval ending in September 2024, Sai Life Sciences reported whole earnings of 693.35 crore, which is a rise from 656.8 crore within the earlier yr. The corporate achieved a web revenue of 28.01 crore for the six months, contrasting with a lack of 12.92 crore throughout the identical interval final yr.

Additionally Learn | Sai Life Sciences IPO opens subsequent week. GMP, value band, date, different particulars

Tentatively, Sai Life Sciences IPO foundation of allotment of shares will likely be finalised on Monday, December 16, and the corporate will provoke refunds on Tuesday, December 17, whereas the shares will likely be credited to the demat account of allottees on the identical day following refund. Sai Life Sciences share value is more likely to be listed on BSE and NSE on Wednesday, December 18.

- Advertisement -
Additionally Learn | Mobikwik IPO: GMP, value band, different key particulars of upcoming IPO

 

Sai Life Sciences IPO GMP in the present day

Sai Life Sciences IPO GMP in the present day is +37.50. This means Sai Life Sciences share value was buying and selling at a premium of 37.50 within the gray market, in response to investorgain.com.

Contemplating the higher finish of the IPO value band and the present premium within the gray market, the estimated itemizing value of Sai Life Sciences share value is indicated at 586.5 apiece, which is 6.83% greater than the IPO value of 549.

At present, the Gray Market Premium (GMP) for the upcoming IPO is demonstrating a optimistic upward development, reflecting rising investor confidence. Over the past 4 periods of gray market actions, the GMP has different between 22 and 42, in accordance investorgain.com specialists.

- Advertisement -

‘Gray market premium’ signifies buyers’ readiness to pay greater than the difficulty value.

Additionally Learn | Sai Life Sciences IPO opens on December 11; value band set at ₹522-549

Sai Life Sciences IPO particulars

The IPO contains a brand new issuance of fairness shares valued at a most of 950 crore, together with an Supply For Sale (OFS) of as much as 3.81 crore fairness shares by a promoter, investor shareholders, and numerous different shareholders, as acknowledged within the RHP.

Underneath the OFS, one of many entities managed by the promoters — Sai Quest Syn Pvt Ltd — together with investor shareholders — TPG Asia VII SF Pte Ltd and HBM Personal Fairness India — will divest their particular person stakes.

Bharathi Srivari, Anita Rudraraju Nandyala, Raju Penmasta, Dirk Walter Sartor, Jagdish Viswanath Dore, Rajagopal Srirama Tatta, and Ok Pandu Ranga Raju are among the many different shareholders who can even promote their parts of the corporate. On the higher band of the value vary, the agency is anticipated to boost roughly 3,042.62 crore via the IPO.

Kotak Mahindra Capital Firm Ltd, IIFL Capital Companies Ltd (beforehand generally known as IIFL Securities Ltd), Jefferies India, and Morgan Stanley India Firm are the lead managers for the guide operating course of, whereas KFin Applied sciences serves because the registrar for the IPO.

Additionally Learn | Vishal Mega Mart IPO: GMP jumps; value, date, different particulars of upcoming IPO

Disclaimer: The views and proposals above are these of particular person analysts, specialists and broking corporations, not of Mint. We advise buyers to verify with licensed specialists earlier than making any funding choice.

Catch all of the Enterprise Information , Market Information , Breaking Information Occasions and Newest Information Updates on Reside Mint. Obtain The Mint Information App to get Every day Market Updates.

Enterprise NewsMarketsIPOTPG-backed Sai Life Sciences IPO: Right here’s what GMP indicators forward of situation opening on Wednesday, December 11

ExtraMuch less

- Advertisement -
- Advertisement -

More articles

Latest article

spot_imgspot_imgspot_imgspot_img